Asio Capital, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Asio Capital, LLC

$460 Million
Q1 2024

A detailed history of Asio Capital, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Asio Capital, LLC holds 2,545 shares of REGN stock, worth $2.68 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

2,545

Previous 2,502 1.72%

Holding current value

$2.68 Million

Previous $2.2 Million 11.47%

% of portfolio

0.53%

Previous 0.52%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	BUY	$902.69 - $993.35 $38,815 - $42,714	43 Added 1.72%	2,545 $2.45 Million
Q4 2023 Jan 11, 2024	BUY	$775.18 - $881.7 $26,356 - $29,977	34 Added 1.38%	2,502 $2.2 Million
Q3 2023 Oct 31, 2023	BUY	$692.45 - $844.37 $137,105 - $167,185	198 Added 8.72%	2,468 $2.03 Million
Q2 2023 Aug 03, 2023	BUY	$700.03 - $830.35 $18,900 - $22,419	27 Added 1.2%	2,270 $1.63 Million
Q1 2023 Apr 24, 2023	BUY	$680.49 - $826.97 $58,522 - $71,119	86 Added 3.99%	2,243 $1.84 Million

Q4 2022 Jan 27, 2023	SELL	$705.89 - $766.39 $1.56 Million - $1.69 Million	-2,204 Reduced 50.54%	2,157 $0
Q3 2022 Oct 27, 2022	BUY	$573.97 - $724.32 $226,144 - $285,382	394 Added 9.93%	4,361 $3 Million
Q2 2022 Aug 04, 2022	BUY	$548.35 - $738.84 $50,448 - $67,973	92 Added 2.37%	3,967 $2.35 Million
Q1 2022 Apr 28, 2022	BUY	$595.12 - $698.43 $279,111 - $327,563	469 Added 13.77%	3,875 $2.71 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $204,348 - $252,284	376 Added 12.41%	3,406 $2.15 Million
Q3 2021 Nov 01, 2021	BUY	$574.03 - $680.96 $377,711 - $448,071	658 Added 27.74%	3,030 $1.83 Million
Q2 2021 Jul 30, 2021	BUY	$472.8 - $558.54 $284,625 - $336,241	602 Added 34.01%	2,372 $1.33 Million
Q1 2021 May 05, 2021	BUY	$446.73 - $548.2 $790,712 - $970,314	1,770 New	1,770 $837,000

Others Institutions Holding REGN

# of Institutions

1,427

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asio Capital, LLC with notifications on news.

Account